PresentationGood afternoon. Thank you for joining us for another session at the 44th JPMorgan Healthcare Conference. I'm Brian Cheng. I'm one of the senior biotech analysts here at the firm. On stage, we have the CEO of Roivant joining us.Matthew GlineCEO & Director Thanks, Brian. Thanks, everyone, for being here. We did quite a long Investor Day in December. So this is going to be in part a recapitulation of that and in part just an opportunity for me to test some stand up material because I don't actually ...